<DOC>
	<DOCNO>NCT00205777</DOCNO>
	<brief_summary>The purpose study determine whether bazedoxifene acetate safe effective treatment osteoporosis postmenopausal woman .</brief_summary>
	<brief_title>Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Must least 2 year postmenopausal Osteoporotic subject without vertebral fracture meet BMD criterion , Osteoporotic subject vertebral fracture Diseases may affect bone metabolism Vasomotor symptoms require treatment Known history suspect cancer breast Active past history venous thromboembolic event</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>Postmenopause</keyword>
</DOC>